Deer Park, IL and New Orleans, LA – March 17, 2026 – Airway Innovations, Inc., a medical device company dedicated to improving the safety, efficiency, and cost-effectiveness of deep I.V. sedation, TIVA, and post-extubation airway management, today announced an exclusive distribution partnership with Medical Specialties, Inc. to represent the AERIS Airway™ across key hospital-based and ambulatory care settings.
Medical Specialties, Inc. is a medical device distributor with over 50 years of experience bringing best-in-class technology in respiratory, anesthesia, critical care, and EMS to hospitals and healthcare systems by providing product expertise, training, and ongoing clinical support. The territory covered by Medical Specialties includes Alabama, Arkansas, Louisiana, Mississippi, Tennessee, and the Florida Panhandle.
Under the agreement, Medical Specialties will market, sell, and support the AERIS Airway, an innovative device that converts standard adult Guedel oropharyngeal airways (OPAs) and adult nasopharyngeal airways (NPAs) into advanced supraglottic oxygenation and capnography systems. By delivering a high fraction of inspired oxygen (FIO₂) at low oxygen flow rates and enabling continuous end-tidal CO₂ monitoring, the AERIS Airway is designed to reduce the risk of hypoxemia, streamline the anesthesia workflow, and facilitate lower overall surgical and procedural costs.
“The AERIS Airway is a low-cost, high-impact device that addresses a critical gap when OPAs and NPAs are used by keeping patients safe, well-oxygenated, and continuously monitored—without adding complexity or financial cost,” said Paul Fehrenbacher, Chief Executive Officer of Airway Innovations. “Medical Specialties has spent decades introducing high-impact respiratory and anesthesia technologies to critical care clinicians, and their focus on education and bedside support makes them a great partner to accelerate adoption of the AERIS Airway across hospital operating and procedure rooms and outpatient facilities.”
The AERIS Airway seamlessly fits into standard adult Guedel OPAs and adult NPAs, allowing anesthesia providers to incorporate the device into their current workflow with minimal change. The device delivers FIO₂ up to 80% at oxygen flows as low as 2–4 L/min and up to 100% at 6–10 L/min, while capturing real-time, high-fidelity capnography waveforms to support ventilatory decision-making. The AERIS Airway can be used whenever an adult Guedel OPA or NPA is used, including during deep I.V. sedation, TIVA, post-extubation, and in emergency medical settings. Importantly, the AERIS Airway exceeds the ASA guidelines for monitoring ETCO2 during I.V. sedation and TIVA.
“Medical Specialties is committed to identifying and introducing technologies that improve patient outcomes in respiratory and anesthesia care,” said Susan Arthur, Vice President at Medical Specialties, Inc. “The AERIS Airway aligns perfectly with what our anesthesia and critical care customers are asking for: a simple, disposable solution that enhances oxygenation and CO₂ monitoring without requiring major changes to their current workflow.”
Healthcare providers interested in evaluating the AERIS Airway can contact their local Medical Specialties representative or reach Airway Innovations directly for more information and to schedule a demonstration.
About Airway Innovations, Inc.
Airway Innovations is an Illinois-based medical device company focused on creating intuitive, evidence-informed airway management solutions that improve patient safety, simplify provider workflow, and reduce the cost of care. The company’s flagship product, the AERIS Airway™, is designed to modernize deep sedation by combining efficient supraglottic oxygen delivery with continuous capnography in a simple, disposable device. For more information, visit airwayinnovations.com or contact info@airwayinnovations.com.
About Medical Specialties, Inc.
Medical Specialties, Inc. is a privately held medical equipment company with more than 50 years of experience delivering best-in-class technology in respiratory, anesthesia, critical care, and EMS. As a specialty distributor, Medical Specialties focuses on introducing new technology to the market, calling on ICU, NICU, emergency, surgery, and other critical care departments while working closely with manufacturers to provide innovative, high-quality, and cost-effective healthcare products. For more information, visit medspecialties.com or email sales@medspecialties.com.
Airway Innovations Contact:
Chris Klecher, SVP Sales & Marketing
chris.klecher@airwayinnovations.com
949.310.8271
Medical Specialties Contact:
Susan Arthur, Vice President
susan@medspecialties.com
504.734.1171